National Virtual Biotechnology Laboratory Symposium

Start

Wed, 28 Oct 2020, 17:30

End

Wed, 28 Oct 2020, 21:30

WebSite

https://iii.hm/nvblsymposium2020

Venue:

Speakers

NVBL Co-Leads Michelle Buchanan, Oak Ridge National Laboratory, and Stephen Streiffer, Argonne National Laboratory

Bruce Tromberg, Director, National Institute of Biomedical Imaging & Bioengineering, National Institutes of Health

Jim Brase, Deputy Associate Director for Computation, Lawrence Livermore National Laboratory

Greg Burel, President, Hamilton Grace, LLC

Harriet Kung, Deputy Director for Science, DOE Office of Science

Exhibit

Symposia

Workshops

Organiser

Sponsor

The symposium is a virtual event to highlight the impact the U.S. Department of Energy’s (DOE) National Virtual Biotechnology Laboratory (NVBL) has had utilizing the unique capabilities of the DOE to tackle the science and technology challenges associated with COVID-19, and to discuss areas in which the NVBL can have impact in the future. With perspectives from Chris Fall, Director, Office of Science, DOE, and William A. Bookless, Principal Deputy Administrator of the National Nuclear Security Administration, the event will feature presentations from lead investigators reporting progress in:

Epidemiological modeling
Therapeutics
Testing
Understanding transport of the virus
Solving issues around supply chain challenges

In addition, keynote speakers from outside the NVBL will discuss the upcoming science and technology needs in computing, testing and surveillance, and vaccines.